Reduction in gastric cancer mortality by screening based on serum pepsinogen concentration: a case-control study.

Pepsinogen testing is widely used in Japan as a method of screening for gastric cancer. To evaluate the efficacy of this method, a case-control study was conducted in a rural town in Hiroshima prefecture, Japan, where no previous pepsinogen testing had been performed.
Three age-and gender-matched control subjects were randomly selected for each of 41 individuals who had died of gastric cancer. The three control subjects were selected from individuals who were living in the same area as the patient when gastric cancer was diagnosed.
The odds ratios for death from gastric cancer among control subjects screened within 1 and 2 years before the individuals were diagnosed versus those not screened were 0.238 (95% confidence interval (CI): 0.061-0.929), and 0.375 (95% CI: 0.155-0.905), respectively.
The study results suggest that gastric cancer screening using the pepsinogen method may reduce mortality from gastric cancer.
AuthorsMasaharu Yoshihara, Toru Hiyama, Shigeto Yoshida, Masanori Ito, Shinji Tanaka, Yoshiyuki Watanabe, Ken Haruma
JournalScandinavian journal of gastroenterology (Scand J Gastroenterol) Vol. 42 Issue 6 Pg. 760-4 (Jun 2007) ISSN: 0036-5521 [Print] Norway
PMID17505999 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Pepsinogen A
  • Aged
  • Aged, 80 and over
  • Case-Control Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pepsinogen A (blood)
  • Stomach Neoplasms (blood, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: